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Gregory L. Moneta, MD, Section EditorAge-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary
Embolism: The ADJUST-PE Study
Righini M, Van Es J, Den Exter PL, et al. JAMA 2014;311:1117-24.
Conclusions: Compared with a ﬁxed D-dimer cutoff 500 mg/L, a
combination of pretest clinical probability assessment with age-adjusted
D-dimer cutoff is associated with a large number of patients in whom PE
can be considered ruled out with a low likelihood of subsequent clinical
venous thromboembolism (VTE).
Summary: In patients with currently suspected acute pulmonary em-
bolism (PE) sequential diagnostic tests, such as clinical probability assess-
ment, plasma D-dimer measurement, compression ultrasound, computed
tomography pulmonary angiography (CTPA), or ventilation-perfusion lung
scanning is used as a standard diagnostic approach. D-dimer testing has
also been evaluated extensively for the exclusion of PE particularly in outpa-
tients (Righini M et al, J Thromb Haemost 2008;6:1059-71). However,
D-dimer levels normally increase with age. Therefore the clinical usefulness
of the test may be limited in older patients. Previously it was found that
D-dimer testing was able to rule out PE in 60% of patients younger than
40 years, but only 5% of patients older than 80 years (Righini M, et al. J
ThrombHaemost 2007;5:1869-77). The authors here have previously retro-
spectively determined a progressive D-dimer cutoff adjusted for age in a sam-
ple of 1712 patients. They deﬁned optimal age-adjusted cutoff as the patients
age multiplied by 10 in patients 50 years or older (Douma RA et al, BMJ
2010;340:c1475). To conﬁrm the utility of this cutoff a multicenter, multi-
national, prospective management outcome study was conducted in 19 cen-
ters in Belgium, France, The Netherlands, and Switzerland between January
1, 2010 and February 28, 2013. Consecutive patients who presented to the
emergency department with clinical suspected PE were assessed by a sequen-
tial diagnostic strategy based on the clinical probability assessmeny with the
revised Geneva score or the 2-level Wells score for PE; high sensitive D-dimer
measurement; and CTPA. Patients with D-dimer values between the conven-
tional cutoff of 500 mg/L and their age-adjusted cutoff did not undergo
CTPA and were left untreated and followed for 3 months. Primary outcome
was the failure rate of the diagnostic strategy, deﬁned as the rate of adjudi-
cated VTE events during the 3 month follow-up period among patients
not treated with anticoagulants on the basis of a negative age-adjusted
D-dimer cutoff result. Of the 3346 patients with suspected PE included in
the study, the prevalence of PE was 19%. Among the 2898 patients with a
nonhigh or an unlikely clinical probability of PE, 817 patients (28.2%) had
a D-dimer level lower than 500 mg/L (95% CI, 26.6%-29.9%), and 337 pa-
tients (11.6%) had a D-dimer between 500 mg/L and their age-adjusted cut-
off (95% CI, 10.5%-12.9%). The 3-month failure rate in patients with a
D-dimer level higher than 500 mg/L but below the age-adjusted cut-off
was 1 of 331 patients (0.3%; 95% CI, 0.1%-1.7%). Among 776 patients 75
years or older, there were who 673 had a non-high clinical probability, using
the age-adjusted cutoff instead of the 500 mg/L cut-off. This increased the
proportion of patients in whomPE could be excluded on the basis of D-dimer
from 43 of 673 patients (6.4%; 95% CI, 4.8%-8.5%) to 200 of 673 patients
(29.7%; 95% CI, 26.4%-33.3%), with no additional false-negative ﬁndings.
Comment: It is important to remember that the ﬁndings for D-dimer
for exclusion of PE, as presented in this study, still applies only to outpatients.
However, it does appear that the use of age-adjusted D-dimer cutoffs in clin-
ical practice for evaluation of PE in outpatients has potential for improved
cost effectiveness and improved quality of care, particularly in older patients.
Additional studies to address these particular issues will be required before
wide-spread adoption of age-adjusted D-dimer cutoffs can be expected.
Progression Rate and Ipsilateral Neurological Events in Asymptomatic
Carotid Stenosis
Hirt LS Stroke 2014;45:702-6.
Conclusions: Rapid rates of progression of carotid artery stenosis
portend signiﬁcantly increased risk of future ipsilateral neurologic events.
Summary: About 3.6% of the general population has a $50% asymp-
tomatic carotid artery stenosis with attendant increased risk of future stroke.
Given that recent evidence suggests stroke risk is fallowing with carotid ste-
nosis identifying those lesions with a particular high risk of stroke would be
important. Potential risk factors for stroke with carotid artery stenosis includethe degree of carotid narrowing, plaque morphology, plaque hemorrhage,
detection of cerebral microemboli, and progression rates of luminal narrow-
ing. Stenosis progression occurrs in 5% to 20% of patients with asymptomatic
carotid stenosis (Norris JW et al, Stroke 1992;23:483-5, and Lewis RF et al,
Ann Intern Med 1997;127:13-20). In this study the authors sought to eval-
uate the yearly rate of change of carotid luminal narrowing as a risk factor for
ipsilateral ischemic neurologic events in patients with $50% asymptomatic
carotid stenosis. Patients were those who took part in the deferred endarter-
ectomy arm of the Asymptomatic Carotid Surgery Trial (ACST). Secondary
aims were to establish the annual incidence of progression and regression of
luminal narrowing and identify other risk factors associated with ipsilateral
neurological events in these patients. This was a retrospective analysis of
data derived from the deferred endarterectomy arm of the Asymptomatic
Carotid Surgery Trial. Patients were followed for $5years with serial carotid
duplex examinations. Data were derived from information obtained at
randomization and annual follow-up visits with carotid duplex studies. Po-
tential risk factors for ipsilateral neurological events were analyzed in Pois-
son regression models. There were data from 1469 patients included. 244
had ipsilateral events; 240 had ipsilateral carotid surgery; 370 died from
nonstroke causes and 82 had an asymptomatic carotid occlusion. The
annual incidence of contralateral symptoms showed a signiﬁcant indepen-
dent association with ipsilateral neurological events. Ipsilateral events
were associated with higher rates of progression over 1 year but not with
low progression rates.
Comment: The results of this study have signiﬁcant implications for
clinical practice. Duplex measurements demonstrating a slow rate of pro-
gression of asymptomatic carotid stenosis should not be interpreted as a
sign of increase risk of future neurologic events. Faster rates of progression
are associated with an increased risk of future ipsilateral neurologic events
and perhaps therefore can be used as one of the variables in the decision
to perform intervention for asymptomatic carotid stenosis.
Clinical and Cost-Effectiveness of Compression Hosiery Versus
Compression Bandages in Treatment of Venous Leg Ulcers (Venous
leg Ulcer Study IV, VenUS IV): A Randomised Controlled Trial
Ashby R, Gabe R, Ali S, et al. Lancet 2014;383:871-9.
Conclusions: Two-layer compression hosiery and four-layer bandages
are equally effective in healing venous leg ulcers.
Summary: Four-layer multi-component compression bandages are
regarded by many as the gold standard compression system to treat
venous leg ulceration (O’Meara S et al, Cochrane Database Syst Rev
2012;(1):CD000265). Two-layer compression hosiery systems have also
been marketed for treatment of venous leg ulcers. They are designed to
deliver 40 mm Hg of compression at the ankle when both layers under-
stocking and overstocking are worn together. Two-layer hosiery is less bulky
than a four-layer bandage and can be more easily worn with shoes and might
enhance ankle or leg mobility and therefore patient adherence. There is
however, little evidence from randomized controlled trials of the effective-
ness of two-layer hosiery for ulcer healing. There have been no trials
comparing two-layer hosiery and four-layer bandages. In this study the au-
thors sought to compare the clinical effectiveness and cost effectiveness of
two-layer hosiery with four-layer bandages for healing of venous ulcers.
This was an open randomized control trial with two parallel groups con-
ducted in 34 centers in England and Northern Ireland. Centers were com-
munity nurse teams or services, family doctor practices, leg ulcer clinics,
tissue viability clinics or services, and wound clinics. Study participants
were 18 years of age or older with a venous leg ulcer and an ankle brachial
pressure index of at least 0.8, and were able to tolerate high compression.
Participants were manually allocated 1:1 to receive two-layer compression
hosiery or a four-layer bandage using a remote randomization service and
a prevalidated computer randomization program. Stratiﬁcation was by ulcer
duration and ulcer area with permuted blocks. The primary end point was
time to ulcer healing with a maximum follow-up of 12 months. Participants
and health-care providers were not masked to treatment allocation but the
primary end point was measured by masked assessment of photographs. Pri-
mary analysis was intention to treat with Cox regression, with adjustment
for ulcer area, ulcer duration, physical mobility and center. Secondary end
points were unmasked outcome assessment, unmasked measurement of1469
